BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1778 related articles for article (PubMed ID: 19394732)

  • 1. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
    Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
    J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
    Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
    QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Díez JJ; Vázquez A
    J Nephrol; 2002; 15(2):136-43. PubMed ID: 12018629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
    Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
    Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
    Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
    J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do inflammatory markers add predictive information of death beyond that provided by age and comorbidity in chronic renal failure patients?
    Caravaca F; Martín MV; Barroso S; Ruiz B; Hernández-Gallego R
    Nephrol Dial Transplant; 2006 Jun; 21(6):1575-81. PubMed ID: 16484235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
    Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization.
    Hung A; Pupim L; Yu C; Shintani A; Siew E; Ayus C; Hakim RM; Ikizler TA
    Hemodial Int; 2008 Apr; 12(2):236-43. PubMed ID: 18394058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
    Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of malnutrition on mortality in patients on maintenance hemodialysis in Serbia.
    Stojanovic M; Stojanovic D; Stefanovic V
    Artif Organs; 2008 May; 32(5):398-405. PubMed ID: 18471169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
    Vitale C; Gebara O; Mercuro G; Wajngarten M; Silvestri A; Rossini P; Ramires JA; Fini M; Rosano GM
    Maturitas; 2005 Apr; 50(4):239-46. PubMed ID: 15780522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CRP levels in pre-dialysis patients.
    Razeghi E; Parkhideh S; Ahmadi F; Khashayar P
    Ren Fail; 2008; 30(2):193-8. PubMed ID: 18300120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.
    Bradbury BD; Critchlow CW; Weir MR; Stewart R; Krishnan M; Hakim RH
    Nephrol Dial Transplant; 2009 Mar; 24(3):919-25. PubMed ID: 18840893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 89.